Abiopharma

🔍 Ilkbahar Alper (Executive)

Company: Sandisk Corp (SNDK)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 276 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 50,259.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 276 shares of Common Stock at $1600.62 per share (Direct)
  Date: 2026-08-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 49,983.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 163 shares of Common Stock at $1600.62 per share (Direct)
  Date: 2026-08-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 49,820.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 320 shares of Common Stock at $1596.08 per share (Direct)
  Date: 2026-08-21 | Code: F | equity_swap_involved: 0 | shares_owned_after: 49,500.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 276 shares of Performance Shares (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 148,770.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: The reported transaction reflects the conversion of performance stock units to shares solely for the purpose of satisfying FICA tax withholding obligations as a result of the Reporting Person's retirement eligibility. The number of shares represents what was necessary to satisfy the FICA tax liability and related taxes attributable to the conversion itself, of which the shares were simultaneously forfeited to pay for the taxes.
• F2: Represents shares withheld to satisfy the reporting person's tax withholding obligation in connection with the transaction described in Footnote (1) and is exempt pursuant to Rule 16b-3(e).
• F3: Payment of tax obligation by withholding securities incident to the vesting of securities in accordance with Rule 16b-3(e).